As Artificial Intelligence (AI) continues to revolutionize various sectors, market access is no exception. Companies are increasingly exploring the application of Generative AI and other advanced algorithms to enhance their market strategies. However, the effectiveness of AI tools heavily relies on robust data engineering, which remains a challenge for many organizations. Bridging the gap between specific market access use cases and data engineering expertise is essential but often limited by the fact that professionals in market access may lack deep data engineering knowledge, while data engineers may not fully understand the complexities of market access.

• How has Ingenious e-Brain, with its acquisition of InsiMine, transformed market horizon scanning, formulary analytics, Target Product Profile (TPP) assessments, pricing and reimbursement strategies, value message optimization, and customer engagement?
• What challenges are pharmaceutical companies facing with the current AI tools available in the market?
• How can organizations transform vast amounts of data into actionable insights for strategic decision-making?
• How can Ingenious e-Brain help you reduce expenditures on market access strategies while accelerating your market entry?